Perinatally acquired HIV-1 infection: Prevention and evaluation of HIV-exposed infants

Seminars in Pediatric Infectious Diseases

Volumn 16, Issue 4, 2005, Pages 282-295

  Shetty, Avinash K ^a,b  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; COTRIMOXAZOLE; DAPSONE; EFAVIRENZ; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PENTAMIDINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ANEMIA; ANENCEPHALUS; ANOPHTHALMIA; ANTIBIOTIC PROPHYLAXIS; BLOOD TOXICITY; CESAREAN SECTION; CHILD CARE; CLINICAL TRIAL; CONGENITAL MALFORMATION; COUNSELING; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG SAFETY; FEBRILE CONVULSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; MORBIDITY; MORTALITY; NEURAL TUBE DEFECT; OPPORTUNISTIC INFECTION; PERINATAL INFECTION; PNEUMOCYSTIS PNEUMONIA; PREGNANCY; PROGNOSIS; REVIEW; RISK FACTOR; SOCIAL SUPPORT; SYSTEMATIC REVIEW; TUBERCULOSIS; VIRUS LOAD; VIRUS RESISTANCE;

EID: 26444526703     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.spid.2005.06.008     Document Type: Article

References (121)

1. L.M. Mofenson Advances in the prevention of vertical transmission of human immunodeficiency virus Semin Pediatr Infect Dis 14 2003 295 308
2. Centers for Disease Control and Prevention Unexplained immunodeficiency and opportunistic infections in infants - New York, New Jersey, California MMWR 31 1982 665 667
3. E.M. Connor, R.S. Sperling, R. Gelber Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Engl J Med 331 1994 1173 1180
4. L.M. Mofenson American Academy of Pediatrics, Committee on Pediatric AIDS Technical report perinatal human immunodeficiency virus testing and prevention of transmission Pediatrics 106 6 2000 Available at: www.pediatrics.org/cgi/ content/full/106/6/e88 ; Internet; accessed June 29, 2005
5. C.M. Wilfert, J.S. Stringer Prevention of pediatric human immunodeficiency virus Semin Pediatr Infect Dis 15 2004 190 198
6. S.M. King American Academy of Pediatrics Committee on Pediatric AIDS; American Academy of Pediatrics Infectious Diseases and Immunization Committee Evaluation and treatment of the human immunodeficiency virus-1-exposed infant Pediatrics 114 2004 497 505
7. A.K. Shetty, Y. Maldonado Advances in the prevention of perinatal HIV-1 transmission NeoReviews 6 2005 12 25
8. S.F. Davis, R.H. Byers Jr, M.L. Lindergren Prevalence and incidence of vertically acquired HIV infection in the United States JAMA 274 1995 952 955
9. A.K. Shetty, M. Maldonado Preventing mother-to-child transmission of human immunodeficiency virus type 1 in resource-poor countries Pediatr Infect Dis J 22 2003 553 555
10. UNAIDS 2004 report on the global AIDS epidemic 4th global report 2004 UNAIDS Geneva
11. M.L. Newell, H. Coovadia, M. Cortina-Borja Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children Mortality of infected and uninfected infants born to HIV-infected mothers in Africa A pooled analysis Lancet 364 2004 1236 1243
12. M.G. Fowler, R.J. Simonds, A. Roongpisuthipong Update on perinatal HIV transmission Pediatr Clin North Am 47 2000 21 38
13. M.G. Fowler, M.L. Newell Breastfeeding and HIV-1 transmission in resource-limited settings J Acquir Immune Defic Syndr 30 2002 230 239
14. J.P.A. Ioannidis, E.J. Abrams, A. Ammann Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml J Infect Dis 183 2001 539 545
15. L.M. Mofenson, J.S. Lambert, E.R. Stiehm Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine N Engl J Med 341 1999 385 393
16. E.R. Cooper, M. Charurat, L. Mofenson Combination antiretroviral strategies for treatment of pregnant HIV-infected women and prevention of perinatal HIV-1 transmission J Acquir Immune Defic Syndr 29 2002 484 494
17. R.S. Sperling, D.E. Shapiro, R.W. Coombs Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant N Engl J Med 335 1996 1621 1629
18. R. Chuachoowong, N. Shaffer, W. Siriwasin Bangkok Collaborative Perinatal HIV Transmission Study Group Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission J Infect Dis 181 2000 99 106
19. R.E. Tuomala, P.T. O'Driscoll, J.W. Bremer Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women J Infect Dis 187 2003 375 384
20. N.A. Wade, G.S. Birkhead, B.L. Warren Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus N Engl J Med 339 1998 1409 1414
21. C. Rouzoiux, D. Costagliola, M. Burgard Estimated timing of mother-to-child human immunodeficiency virus type 1 transmission by use of Markov model Am J Epidemiol 142 1995 1330 1337
22. N. Shaffer, R. Chuachoowong, P.A. Mock Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand A randomized controlled trial Lancet 353 1999 773 780
23. M. Lallemant, G. Jourdain, S. Le Coeur A trial of shortened zidovudine regimens to prevent mother-to child transmission of human immunodeficiency virus type 1 N Engl J Med 343 2000 982 991
24. S.Z. Wiktor, E. Ekpini, J.M. Karon Short-course zidovudine for prevention of mother-to child transmission of HIV-1 in Abidjan, Cote d'Ivoire A randomized trial Lancet 353 1999 781 785
25. F. Dabis, P. Msellati, N. Meda 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce transmission of HIV in breastfed children in cote d'Ivoire and Burkina Faso A double-blind placebo-controlled multicentre trial Lancet 353 1999 786 792
26. V. Leroy, J.M. Karon, A. Alioum Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother to child transmission of HIV-1 in West Africa AIDS 16 2002 631 641
27. L. Mandelbrot, A. Landrequ-Mascaro, C. Rekacewicz Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1 JAMA 285 2001 2083 2093
28. P. Chaisilwattana, K. Chokephaibulkit, A. Chalermchockcharoenkit Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand Clin Infect Dis 335 2002 1405 1413
29. The PETRA Study Team Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study) A randomised, double-blind, placebo-controlled trial Lancet 359 2002 1178 1186
30. M. Mirochnick, T. Fenton, P. Gagnier Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates J Infect Dis 178 1998 368 374
31. L.A. Guay, P. Musoke, T. Fleming Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 Kampala, Uganda HIVNET 012 randomized trial Lancet 354 1999 795 802
32. J.B. Jackson, P. Musoke, T. Feming Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 Kampala, Uganda 18 month follow-up of the HIVNET 012 randomized trial Lancet 362 2003 859 868
33. D. Moodley, J. Moodley, H. Coovadia A multicenter randomized trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of HIV-1 J Infect Dis 187 2003 725 735
34. M. Lallemant, G. Jourdain, S. Le Coeur Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand N Engl J Med 351 2004 217 228
35. F. Dabis, L. Bequent, D.K. Ekouevi Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission AIDS 2005 19 2005 309 318
36. A. Dorenbaum, C.K. Cunningham, R.D. Gelber Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission a randomized trial JAMA 288 2002 189 198
37. C.K. Cunningham, M.L. Chaix, C. Rekaecewicz Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission A substudy of pediatric AIDS clinical trials group protocol 316 J Infect Dis 186 2002 181 188
38. T.E. Taha, N. Kumwenda, D.R. Hoover Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting a randomized controlled trial JAMA 292 2004 202 209
39. M. Nolan, M.G. Fowler, L.M. Mofenson Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance J Acquir Immune Defic Syndr 30 2002 216 229
40. Treat 3 Million by 2005 Initiative. Treating 3 million by 2005 Making it happen - The WHO and UNAIDS global initiative to provide antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005. World Health Organization Web site. Available at: http://www.who.int/3by5/ publications/documents/en/3by5StrategyMakingItHappen.pdf ; Internet; accessed June 29, 2005
41. S.H. Eshleman, M. Mracna, L. Guay Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) AIDS 15 2001 1951 1957
42. G. Jourdain, N. Ngo-Giang-Huong, S. Le Coeur Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy N Engl J Med 351 2004 229 240
43. H. Coovadia Antiretroviral agents - how best to protect infants from HIV and save their mothers from AIDS N Engl J Med 351 2004 289 292
44. S.H. Eshleman, L.A. Guay, A. Mwatha Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012) J Acquir Immune Defic Syndr 35 2004 126 130
45. The International Perinatal HIV Group The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 A meta-analysis of 15 prospective studies N Engl J Med 340 1999 977 987
46. The European Mode of Delivery Collaboration Elective caesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission A randomized clinical trial Lancet 353 1999 1035 1039
47. D.H. Watts, J.S. Lambert, E.R. Stiemh Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of ≤500/uL Am J Obstet Gynecol 183 2000 100 107
48. J.S. Read, R. Tuomala, E. Kpamegan Mode of delivery and postpartum morbidity among HIV-infected women The Women and Infants Transmission Study J Acquir Immune Defic Syndr 26 2001 236 245
49. M. Bulterys, A. Chao, A. Dushimimana Fatal complication after Caesarean section in HIV infected women AIDS 10 1996 923 924
50. L.M. Mofenson Successes and challenges in the perinatal HIV-1 epidemic in the United States as illustrated by the HIV-1 serosurvey of childbearing women Arch Pediatr Adolesc Med 158 2004 422 425
51. M.L. Lindegren, R.H. Byers Jr, P. Thomas Trends in perinatal HIV/AIDS in the United States JAMA 282 1999 531 538
52. M. Bulterys, D.J. Jameison, M.J. O'Sullivan Rapid HIV-1 testing during labor A multicenter study JAMA 292 2004 219 233
53. M.H. Cohen, Y. Olszewski, B. Branson Using point of care testing to make rapid HIV-1 test in labor really rapid [letter] AIDS 17 2003 2121 2124
54. J.S. Read American Academy of Pediatrics, Committee on Pediatric AIDS Technical report Human milk, breastfeeding, and the transmission of HIV-1 infection in the United States Pediatrics 112 2003 1196 1205
55. Centers for Disease Control and Prevention U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States MMWR Recomm Rep 51 RR-18 2002 1 40
56. A.D. Bardeguez, D.E. Shapiro, L.M. Mofenson Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival J Acquir Immune Defic Syndr 32 2003 170 181
57. American Academy of Pediatrics, Advisory Committee on Immunization Practices, American Academy of Family Physicians Recommended childhood immunization schedule - United States, 2002 Pediatrics 109 2002 162 164
58. American Academy of Pediatrics Human immunodeficiency virus infection L.K. Pickering Red Book (ed 26) 2003 American Academy of Pediatrics Elk Grove Village, IL 360 382
59. K. Nielsen, Y.J. Bryson Diagnosis of HIV infection in children Pediatr Clin North Am 2000 47 2000 39 63
60. D.T. Dunn, C.D. Brandt, A. Krivine The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intr-auterine and intra-partum transmission AIDS 9 suppl 1995 7 11
61. N.E. Kline, H. Schwarzwald, M.W. Kline False negative DNA polymerase chain reaction in an infant with subtype C human immunodeficiency virus 1 infection Pediatr Infect Dis J 21 2002 885 886
62. J. Haas, M. Geiss, T. Bohler Infection with non-B subtype HIV type 1 complicates management of established infection in adult patients and diagnosis of infection in infant infants Clin Infect Dis 34 2002 417 418
63. C.K. Cunningham, T.T. Charbonneau, K. Song Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants Pediatr Infect Dis J 18 1999 30 35
64. R.J. Simonds, T.M. Brown, D.M. Thea Sensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants. Perinatal AIDS Collaborative Transmission Study AIDS 12 1998 1545 1549
65. F. Rouet, C. Montcho, C. Rouzioux Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay AIDS 15 2001 1849 1856
66. P.L. Havens, D. Waters Management of the infant born to a mother with HIV infection Pediatr Clin N Am 51 2004 909 937
67. N.L. Young, N. Shaffer, T. Chaowanachan Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes J Acquir Immune Defic Syndr 24 2000 401 407
68. Y.J. Bryson, K. Luzuriaga, J.L. Sullivan Proposed definitions for in utero versus intrapartum transmission of HIV-1 N Engl J Med 327 1992 1246 1247
69. Centers for Disease Control and Prevention Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome MMWR Recomm Rep 48 RR-13 1999 1 27 29-31
70. K. McIntosh, J. Pitt, D. Brambilla The Women and Infants Transmission Study Group Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection J Infect Dis 170 1994 996 1000
71. A. Krivine, A. Yakudima, M. Le May A comparative study of virus isolation, polymerase chain reaction, and antigen detection in perinatally acquired human immunodeficiency virus J Pediatr 116 1990 372 376
72. R.J. Simonds, M.J. Oxtoby, M.B. Caldwell Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection JAMA 270 1993 470 473
73. US Public Health Service, Infectious Diseases Society of America, Prevention of Opportuntistic Infections Working Group 2001 USPHS/IDSA Guidelines for the Prevention of Opportunitistic Infections in Persons Infected with Human Immunodeficiency Virus 2001 AIDSinfo, National Institutes of Health Rockville, MD
74. D.V. Havlir, P.F. Barnes Tuberculosis in patients with human immunodeficiency virus infection N Engl J Med 340 1999 367 373
75. L.T. Gutman, J. Moye, B. Zimmer Tuberculosis in human immunodeficiency virus-exposed or infected United States children Pediatr Infect Dis J 13 1994 963 968
76. American Thoracic Society/Centers for Disease Control and Prevention Supplement Targeted tuberculin testing and treatment of latent tuberculosis infection Am J Respir Crit Care Med 161 suppl 2000 221 247
77. American Academy of Pediatrics Tuberculosis L.K. Pickering Red Book (26th ed) 2003 American Academy of Pediatrics Elk Grove Village, IL 642 660
78. American Academy of Pediatrics, Committee on Pediatric AIDS Planning for children whose parents are dying of HIV/AIDS Pediatrics 103 1999 509 511
79. American Academy of Pediatrics, Committee on Pediatric AIDS Identification and care of HIV-exposed and HIV-infected infants, children, and adolescents in foster care Pediatrics 106 2000 149 153
80. American Academy of Pediatrics, Committee on Pediatric AIDS and Committee on Infectious Diseases Issues related to human immunodeficiency virus transmission in schools, child care, medical settings, the home, and community Pediatrics 104 1999 318 324
81. L.M. Mofenson, P. Munderi Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants J Acquir Immune Defic Syndr 30 2002 200 215
82. R.S. Sperling, D.E. Shapiro, G.D. McSherry Safety of the maternal-infant zidovudine utilized in the Pediatric AIDS Clinical Trial Group 076 Study AIDS 12 1998 1805 1813
83. M. Culnane, M.G. Fowler, S.S. Lee Lack of long-term effects of in-utero exposure to zidovudine among uninfected children born to HIV-infected women JAMA 281 1999 151 157
84. The European Collaborative Study and the Swiss Mother + Child HIV Cohort Study Combination antiretroviral therapy and duration of pregnancy AIDS 14 2000 2913 2920
85. R.E. Tuomala, D.E. Shapiro, L.M. Mofenson Antiretroviral therapy during pregnancy and the risk of an adverse outcome N Engl J Med 354 2002 1084 1089
86. Antiretroviral Pregnancy Registry Steering Committee Antiretroviral Pregnancy Registry interim report for 1 January 1989 through 31 January 2002 2002 Registry Coordinating Center Wilmington, NC
87. S. Blanche, M. Tardieu, P. Rustin Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues Lancet 354 1999 1084 1089
88. French Perinatal Study Group Risk of early febrile seizure with perinatal exposure to nucleoside analogues Lancet 359 2002 583 584
89. Perinatal Safety Review Working Group Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs Absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohort J Acquir Immune Defic Syndr 25 2000 261 268
90. The European Collaborative Study Exposure to antiretroviral therapy in utero or early life The health of uninfected children born to HIV-infected women J Acquir Immune Defic Syndr 32 2003 380 387
91. K. Luzuriaga, H. Wu, M. McManus Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants J Virol 73 1999 362 367
92. S. Blanche, M.L. Newell, M.J. Mayaux The French Pediatric HIV Infection Study Group and European Collaborative Study Morbidity and mortality in European children vertically infected by HIV-1 J Acquir Immune Defic Syndr Hum Retrovirol 14 1997 442 450
93. G.B. Scott, C. Hutto, R.W. Makuch Survival in children with perinatally acquired human immunodeficiency virus type 1 infection N Engl J Med 321 1989 1791 1796
94. R.W. Marion, A.A. Wiznia, G. Hutcheon Human T-cell lymphotropic virus type III (HTLV-III) embryopathy a new dysmorphic syndrome associated with intrauterine HTLV-III infection Am J Dis Child 140 1986 638 640
95. Q.H. Qazi, T.M. Sheikh, S. Fikrig Lack of evidence for craniofacial dysmorphism in perinatal human immunodeficiency virus infection J Pediatr 112 1998 7 11
96. L. Galli, M. deMartino, P.A. Tovo Italian Register for HIV Infection in Children Onset of clinical signs with HIV-1 perinatal infection AIDS 9 1995 455 461
97. M.L. Newell, C. Peckham, D. Dunn Natural history of vertically-acquired human immunodeficiency virus-1 infection. The European Collaborative Study Pediatrics 94 1994 815 819
98. L.M. Mofenson, J. Oleske, L. Serchuck Treating opportunistic infections among HIV-exposed and infected children Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America MMWR Recomm Rep 53 RR-14 2004 1 92
99. H. Pollack, H. Glasberg, E. Lee Impaired early growth of infants perinatally infected with human immunodeficiency virus Correlation with viral load J Pediatr 130 1997 915 922
100. M.W. Kline Vertically acquired human immunodeficiency virus infection Semin Pedatr Infect Dis 10 1999 147 153
101. Centers for Disease Control Revision of the CDC surveillance case definition for acquired immune deficiency syndrome MMWR 36 suppl 1 1987 1 15
102. Centers for Disease Control and Prevention 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age MMWR 43 RR-12 1994 1
103. B.U. Mueller, P.A. Pizzo Acquired immunodeficiency syndrome in the infant J.S. Remington J.O. Klein Infectious Diseases of the Fetus and Newborn Infant (ed 5) 2001 WB Saunders Philadelphia 447 475
104. F.J. Palella Jr., K.M. Delaney, A.C. Moorman Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med 338 1998 853 860
105. S.L. Gortmaker, M. Hughes, J. Cervia Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1 N Engl J Med 345 2001 1522 1528
106. Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children Guidelines for the use of antiretroviral agents in pediatric HIV infection 2005 AIDSInfo Rockville, MD March 24. Available at: http://AIDSinfo.nih.gov ; Internet; accessed June 29, 2005
107. N. Sharland, G.C. di Zub, J.T. Ramos PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection HIV Med 3 2002 215 226
108. E.J. Abrams, L. Kuhn Should treatment be started among all HIV-infected children and then stopped? Lancet 362 2003 1595 1596
109. L. Gray, M.L. Newell, C. Thorne Fluctuations in symptoms in human immunodeficiency virus-infected children the first 10 years of life Pediatrics 108 2001 116 122
110. C. Diaz, C. Hanson, E.R. Cooper Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth The Women and Infants Transmission Study (WITS) J Acuir Immune Defic Syndr Hum Retrovirol 18 1998 221 228
111. G.M. Anabwani, E.A. Woldetsadik, M.W. Kline Treatment of human immunodeficiency virus (HIV) in children using antiretroviral drugs Semin Pediatr Infect Dis 16 2005 116 124
112. K. Luzuriaga, M. McManus, L.M. Mofenson A trial of three antiretroviral regimens in HIV-1 infected children N Engl J Med 350 2004 2471 2480
113. K. Luzuriaga, Y. Bryson, P. Krogstad Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection N Engl J Med 336 1997 1343 1349
114. K. Luzuriaga, M. McManus, M. Catalina Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection Control of viral replication and absence of persistent HIV-1 specific immune responses J Virol 74 2000 6984 6991
115. M. Hainaut, C.A. Peltier, M. Gerard Effectiveness of antiretroviral therapy initiated before the age of 2 months in infants vertically infected with human immunodeficiency virus type 1 Eur J Pediatr 159 2000 778 782
116. A. Faye, C. Bertone, J.P. Teglas Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1 infected infants Pediatr Infect Dis J 21 2002 518 525
117. Paediatric European Network for Treatment of AIDS (PENTA) Highly active antiretroviral therapy started in infants under 3 months of age 72 week follow-up for CD4 cell count, viral load and drug resistance outcome AIDS 18 2004 237 245
118. C. Litalien, A. Faye, A. Compagnucci Pharmacokinetics of nelfinavir and its active metabolite, hydroxyl-tert-butylamide, in infants less than 1 year old perinatally infected with HIV-1 Pediatr Infect Dis J 22 2003 48 56
119. D.W. Hoody, C.V. Fletcher Pharmacology considerations for antiretroviral therapy in human immunodeficiency virus (HIV)-infected children Semin Pediatr Infect Dis 14 2003 286 294
120. R.E. McKinney, C.K. Cunningham Newer treatment for HIV in children Curr Opin Pediatr 16 2004 76 79
121. C. Thorne, M.L. Newell, F.A. Botet Older children and adolescents surviving with vertically acquired infection J AIDS 29 2002 396 401